UM

Browse/Search Results:  1-5 of 5 Help

Selected(0)Clear Items/Page:    Sort:
Fast identification of anticancer constituents in Forsythiae Fructus based on metabolomics approaches Journal article
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018,Volume: 154,Page: 312-320
Authors:  Bao, Jiaolin;  Ding, Ren-Bo;  Jia, Xuejing;  Liang, Yeer;  Liu, Fang;  Wang, Kai;  Zhang, Chao;  Li, Peng;  Wang, Yitao;  Wan, Jian-Bo;  He, Chengwei
View  |  Adobe PDF(2154Kb)  |  Favorite  |  View/Download:177/21  |  Submit date:2018/10/30
Forsythiae Fructus  Anticancer  Metabolomics  Multivariate Data Analysis  B16-f10 Melanoma  
Differences in Chemical Component and Anticancer Activity of Green and Ripe Forsythiae Fructus Journal article
AMERICAN JOURNAL OF CHINESE MEDICINE, 2017,Volume: 45,Issue: 7,Page: 1513-1536
Authors:  Bao, Jiaolin;  Ding, Ren-Bo;  Liang, Yeer;  Liu, Fang;  Wang, Kai;  Jia, Xuejing;  Zhang, Chao;  Chen, Meiwan;  Li, Peng;  Su, Huanxing;  Wan, Jian-Bo;  Wang, Yitao;  He, Chengwei
Unknown(1039Kb)  |  Favorite  |  View/Download:116/4  |  Submit date:2018/10/30
Forsythia Suspensa  Metabolomics  Forsythoside  Anticancer  B16 Melanoma  
Diversity of Pharmacy Faculty Members between UK and US Journal article
INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2017,Volume: 51,Issue: 1,Page: 20-24
Authors:  Zhang, Weixiang;  Wang, Yitao;  Ouyang, Defang
View  |  Adobe PDF(3225Kb)  |  Favorite  |  View/Download:120/6  |  Submit date:2018/10/30
Diversity  Pharmacy Faculty  Comparison  Us  Uk  
Forsythiae Fructus Inhibits B16 Melanoma Growth Involving MAPKs/Nrf2/HO-1 Mediated Anti-Oxidation and Anti-Inflammation Journal article
American Journal of Chinese Medicine, 2016,Volume: 44,Issue: 5,Page: 1043
Authors:  Bao J.;  DIng R.;  Zou L.;  Zhang C.;  Wang K.;  Liu F.;  Li P.;  Chen M.;  Wan J.-B.;  Su H.;  Wang Y.;  He C.
Favorite  |  View/Download:9/0  |  Submit date:2018/10/30
Anti-inflammation  Anti-oxidation  Antitumor  B16 Melanoma  Forsythia Suspensa  Mapks/nrf2/ho-1 Pathway  
Tannic acid is an inhibitor of CXCL12 (SDF-1α)/CXCR4 with antiangiogenic activity Journal article
Clinical Cancer Research, 2003,Volume: 9,Issue: 8,Page: 3115-3123
Authors:  Chen X.;  Beutler J.A.;  McCloud T.G.;  Loehfelm A.;  Yang L.;  Dong H.-F.;  Chertov O.Y.;  Salcedo R.;  Oppenheim J.J.;  Howard O.M.Z.
Favorite  |  View/Download:4/0  |  Submit date:2018/11/06